XML 24 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash Flows From Operating Activities:    
Net loss $ (23,054,434) $ (17,548,085)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 1,454,979 803,261
Issuance of common stock for services 68,000 528,770
Amortization of operating lease right-of-use asset 163,376 151,520
Depreciation 1,492 844
Gain from forgiveness of notes payable – paycheck protection program and accrued interest (166,557)  
Changes in operating assets and liabilities:    
Prepaid expenses (2,619,167) (74,126)
Deposits 19,031
Accounts payable (579,140) (857,307)
Accrued expenses 457,920 (82,185)
Accrued compensation 251,081 254,231
Accrued interest (87,996) 15,673
Operating lease liability (158,999) (123,254)
Net Cash Used In Operating Activities (24,250,414) (16,930,658)
Cash Flows From Investing Activities:    
Purchase of property and equipment (6,938) (1,831)
Purchase of in-process research and development (40,000,000)  
Net Cash Used In Investing Activities (40,006,938) (1,831)
Cash Flows From Financing Activities:    
Proceeds from notes payable – paycheck protection program 164,583
Principal paid on notes payable – related parties (172,970)
Proceeds from sale of NoveCite, Inc. common stock 500
Proceeds from common stock warrant exercises 31,130,134 7,156,549
Proceeds from common stock option exercises 82,634
Net proceeds from underwritten offerings   8,700,201
Net proceeds from private placement 18,450,410
Net proceeds from registered direct offerings 70,979,842 6,877,100
Net Cash Provided By Financing Activities 120,470,550 22,898,433
Net Change in Cash and Cash Equivalents 56,213,198 5,965,944
Cash and Cash Equivalents – Beginning of Year 13,859,748 7,893,804
Cash and Cash Equivalents – End of Year 70,072,946 13,859,748
Supplemental Disclosures of Cash Flow Information and Non-cash Activities:    
Operating lease right-of-use asset and liability recorded upon adoption of ASC 842 $ 1,137,724